At this crisis point in history - what could possibly create these rare and extraordinary gains?

An Arizona multi-millionaire's revolutionary initiative is 
helping average Americans  find quick and lasting stock market success.

Since the Coronavirus came into our lives this slice of the stock market has given ordinary people the chance to multiply their money by 96% in 21 days on JP Morgan.


Stocks  | June 18, 2020

Amana Mutual Funds Trust recently released its Q1 2020 Investor Letter. The Amana Income Fund posted a return of -18.01% for the quarter, outperforming its benchmark, the S&P 500 Index which returned -19.60% in the same quarter. You should check out Amana Mutual Fund's top 5 stock picks for investors to buy right now, which could be the biggest winners of the stock market crash.

In the said letter, Amana Mutual Fund spoke about Eli Lilly & Co (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ) stocks. Eli Lilly and Johnson & Johnson are healthcare companies. Year-to-date, Eli Lilly & Co (NYSE:LLY) stock gained 24.6% and on June 16th it had a closing price of $163.71. Year-to-date, Johnson & Johnson (NYSE:JNJ) stock lost 1% and on June 16th it had a closing price of $144.46. Here is what Amana Mutual Fund said:

"Even so, Lilly stood out as one, among a handful, of companies that registered a positive return for the first quarter. In January, Lilly reported excellent fourth quarter results, with revenue growing at a faster clip than over the first three quarters of the year. Lilly is also financially strong with debt equivalent to only two times EBITDA3 and 12% of market capitalization. Johnson & Johnson, while trailing Lilly, shares many of the same characteristics and also outperformed."

In Q1 2020, the number of bullish hedge fund positions on Eli Lilly & Co (NYSE:LLY) stock remained unchanged from the previous quarter (see the chart here).

In Q1 2020, the number of bullish hedge fund positions on Johnson & Johnson (NYSE:JNJ) stock decreased by about 4% from the previous quarter (see the chart here), so a number of other hedge fund managers don't seem to agree with JNJ's growth potential.

Our calculations showed that Eli Lilly & Co (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ) aren't ranked among the 30 most popular stocks among hedge funds.


A revolutionary initiative is helping average Americans find quick and lasting stock market success.

275% in one week on XLF - an index fund for the financial sector. Even 583%, in 7 days on XHB… an ETF of homebuilding companies in the S&P 500. 


{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

You might also like


Stocks | January 28

Stocks | January 28

Investing, Stocks | January 27

Investing | January 27